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Abstract
Background: The relationship between pathological factors and lymph node metastasis of pathological stage early
gastric cancer has been extensively investigated. By contrast, the relationship between preoperative factors and
lymph node metastasis of clinical stage early gastric cancer has not been investigated. The present study was to
investigate discrepancies between preoperative and postoperative values.
Methods: From January 2011 to December 2013, 1042 patients with clinical stage early gastric cancer who
underwent gastrectomy with lymphadenectomy were enrolled. Preoperative and postoperative values were
collected for subsequent analysis. Receiver operating characteristics curves were computed using independent
predictive factors.
Results: Several discrepancies were observed between preoperative and postoperative values, including existence
of ulcer, gross type, and histology (all McNemar p-values were <0.001). Multivariate analyses identified the
following independent predictive factors for lymph node metastasis: postoperative values including age
(p = 0.002), tumor size (p < 0.001), and tumor depth (p < 0.001); preoperative values including age (p = 0.017),
existence of ulcer (p = 0.037), tumor size (p = 0.009), and prediction of the presence of lymph node metastasis in
computed tomography scans (p = 0.002). These postoperative and preoperative independent predictive factors
produced areas under the receiver operating characteristics curves of 0.824 and 0.660, respectively.
Conclusions: Surgeons need to be aware of limitations in preoperative predictions of the presence of lymph node
metastasis for clinical stage early gastric cancer.
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Background
Gastric cancer is the fifth most common cancer in the
world and the third most common cause of cancer-
related mortality [1]. The incidence of early gastric can-
cer is increasing especially in Korea and Japan because
of improvements in endoscopic diagnosis and the na-
tional screening systems [2–5]. In Korea and Japan, early
gastric cancer has an excellent prognosis after surgical
treatment, with 5-year survival rates of more than 90 %
[5]. Lymph node metastasis in early gastric cancer patients
has been reported to occur in approximately 10–15 % of
cases, and it is one of the strongest prognostic factors for
patients with early gastric cancer [1, 6–8].
The final result of the Dutch trial concluded that gas-
trectomy with D2 lymphadenectomy is a standard surgical
procedure for patients with gastric cancer [9]. According
to the Japanese guideline, which was established based on
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numerous pathological data, standard D2 lymphade-
nectomy is recommended for clinical stage early gas-
tric cancer patients with lymph node metastasis, and
more limited lymphadenectomy such as D1 or D1+
can be options for patients with clinical stage early
gastric cancer without lymph node metastasis [10].
However, preoperative prediction of the presence of
lymph node metastasis for clinical stage early gastric
cancer patients is challenging, and preoperative diag-
nosis carries some degree of inaccuracy, so surgeons
always need to consider the possibility of overstaging
and understaging. Understaging leads to insufficient
treatment, which may exhaust the chance of a cure,
whereas overstaging leads to overtreatment, which
may increase morbidity and mortality and affect the
postoperative quality of life. Although the relationship
between pathological factors and lymph node metasta-
sis of pathological stage early gastric cancer has been
extensively investigated, the relationship between preopera-
tive factors and lymph node metastasis of clinical stage
early gastric cancer has not been investigated [11–15]. The
level of discrepancy between preoperative and postopera-
tive diagnostic values also is not well understood.
The purpose of the present study is to investigate the
discrepancies between preoperative and postoperative
diagnostic values and the relationship between preopera-
tive diagnostic values and lymph node metastasis of clin-
ical stage early gastric cancer.
Methods
Patients and data collection
From January 2011 to December 2013, 1093 patients with
clinical stage early gastric cancer underwent gastrectomy
with lymphadenectomy at Yonsei University Severance
Hospital, Seoul, Korea. Clinical stage early gastric cancer
is defined as a lesion which is preoperatively diagnosed as
confined to the mucosa or submucosa, irrespective of the
regional lymph node metastasis. Diagnosis is primarily
performed using esophagogastroduodenoscopy (EGD)
and computed tomography (CT) scans [16]. Patients with
the following factors were excluded: no EGD (n = 16) or
CT scan report (n = 2) in our hospital, CT scans per-
formed after endoscopic submucosal dissection (n = 15),
incomplete pathological report (n = 9), remnant gastric
cancer (n = 5), and multiple lesions (n = 4). A total of 1042
patients were enrolled into the present cohort. The
following preoperative values of patients were col-
lected: age, gender, body mass index, tumor size, ex-
istence of ulcer, gross type, histology, tumor location,
and neutrophil-lymphocyte ratio. EGD and CT scans
were performed for all patients. Tumor detectability
and prediction of the presence of lymph node metas-
tasis by CT scans were recorded, and endoscopic
ultrasonography (EUS) was performed for some
patients to examine tumor depth and the presence of
perigastric lymph node metastasis. The following
postoperative values of patients were collected: tumor
size, existence of ulcer, gross type, histology, tumor
location, pathological tumor depth, and lymph node
metastasis. This study was conducted in accordance
with the Declaration of Helsinki and was approved by
the Institutional Review Board of Yonsei University
Severance Hospital, which waived the need for written
informed consent from the participants (4-2014-0971).
Preoperative diagnostic methods
Preoperative diagnosis of clinical stage early gastric can-
cer was conducted through preoperative examinations
such as EGD, EUS, and CT scans. Tumor size was mea-
sured using both EGD and EUS. If lesion size was mea-
sured using both EGD and EUS, the larger measurement
was recorded as the representative tumor size [17, 18].
Preoperative CT scan was performed with a multi-
detector row CT scanner (Sensation 16 or 64; Siemens
Medical Solutions, Germany). Patients were instructed
to fast for at least 4 h before the examination. Patients
were prepared by injecting 10 mg butylscopolamine
bromide and giving 2 packs of effervescent granules for
gastric hypotonia and distention. Scanning was per-
formed from the diaphragm to the symphysis pubis, with
the patient in a supine position. A dose of 120–150 ml
contrast medium was administered intravenously at a
rate of 3–4 ml/s using a power injector, and the im-
ages of arterial and portal phases were obtained. CT
scanning parameters were as follows: beam collima-
tion, 0.75 mm × 16 or 0.6 mm × 64; kVp/effective mA,
120/160; and gantry rotation time, 0.5 s. Axial and
coronal images were reconstructed at 3 mm interval
with a slice thickness of 3 mm. If thickening or enhanced
gastric mucosa was observed, it was regarded as a detect-
able tumor. Prediction of the presence of lymph node me-
tastasis was established if the node met two or more of
the following criteria: (1) ≥8 mm diameter in the short-
axis, (2) round shape, (3) enhancement on contrast-
enhanced CT scans, or (4) necrosis.
EUS was performed with radial scanning echoendo-
scopy at 5–12 MHz (GF-UE260; Olympus Optical Co.
Ltd., Tokyo, Japan). The assessment of T-stage with EUS
was based on the generally accepted 5-layer sonographic
structure of the gastric wall. Early gastric cancer lesions
were located within the first three layers, whereas ad-
vanced gastric cancer tumors invaded to the fourth and
fifth layers. The assessment of N-stage with EUS was
based on the existence of metastatic perigastric lymph
nodes. Prediction of the presence of lymph node me-
tastasis was established if the node met two or more
of the following criteria: (1) ≥10 mm in the short-
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axis, (2) round shape, (3) hypoechoic pattern, or (4)
smooth border [19].
Statistical methods
Continuous values were analyzed with mean, standard
deviation, and range. Correspondence between pre-
operative and postoperative values was analyzed using
McNemar and Kappa values. Univariate analyses were
performed using logistic regression analysis. Multivariate
analyses were performed using multiple logistic regres-
sion models with the forward likelihood ratio method.
Pearson’s coefficient correlation was performed to iden-
tify the correlation between two continuous values.
Linear regression analysis was performed to compensate
missing preoperative tumor size based on postoperative
tumor size. A p-value less than 0.05 was regarded as
significant for all analyses. Statistical analyses were per-
formed using SPSS version 19.0 software (IBM SPSS,
Chicago, IL). Receiver operating characteristics curves
were obtained by the probability of finally selected
multivariate logistic regression models and the presence
of lymph node metastasis; the area under the curve, sen-
sitivity, specificity, positive predictive value, and negative
predictive value were calculated using R version 3.0.1
(http://www.R-project.org/) using the “pROC” and
“Optimal Cutpoints” packages and the cutoff point was
determined by the Youden method [20].
Results
Patient data
Baseline characteristics of all patients are shown in
Table 1. Mean age was 58.0 years, 625 patients (60.0 %)
were male, and 417 patients (40.0 %) were female. In
preoperative CT scans, the tumors of 210 patients
(20.2 %) were detectable, and 42 patients (4.0 %) were
suspected to have lymph node metastasis. Pathological
evidence indicated that 74 patients (7.1 %) had lymph
node metastasis, and 81 patients (7.8 %) were diagnosed
with advanced gastric cancer even though each lesion
was considered preoperatively as early gastric cancer.
Several discrepancies were observed between pre-
operative and postoperative diagnostic values including
existence of ulcer, gross type, and histology (McNemar
p-values were <0.001 for all results; κ and p for each
diagnostic value were 0.082 and 0.001, 0.171 and <0.001,
and 0.528 and <0.001, respectively; Table 2). The tumor
size of each case was measured using EGD only in 299
cases (28.7 %), using EUS only in 147 cases (14.1 %), and
using both EGD and EUS in 332 cases (31.9 %). Overall,
the tumor size of 778 cases (74.7 %) was recorded as
preoperative combined size. Correlation coefficients (r
value) between pathological and preoperative tumor size
using EGD (n = 631), EUS (n = 479), and combined size
(n = 778) were 0.330, 0.264, and 0.325, respectively.
Linear regression analysis of the relationship between
pathological and preoperative combined tumor size
also was performed [preoperative combined tumor size
(mm) = 13.049 + 0.206 × Pathological tumor size (mm);
p < 0.001, R2=0.110; Fig. 1). Missing data for preopera-
tive combined tumor sizes [263 cases (25.2 %)] were
compensated using the obtained formula (Additional
file 1: Figure S1).
Postoperative and preoperative predictive factors for
lymph node metastasis
Univariate analysis for postoperative values indicated
that age (p = 0.025), gross type (p < 0.001), histology
(p = 0.001), tumor size (p < 0.001), and tumor depth
(p < 0.001) were significant predictive factors for
lymph node metastasis. Multivariate analysis indicated
that age (p = 0.002), tumor size (p < 0.001), and tumor
depth (p < 0.001) were independent predictive factors
(Table 3).
Univariate analysis for preoperative values indicated
that age (p = 0.025), existence of ulcer (p = 0.041), tumor
size (p = 0.010), and prediction of the presence of lymph
node metastasis in CT scans (p = 0.002) were significant
predictive factors for lymph node metastasis. Multivari-
ate analysis indicated that age (p = 0.017), existence of
ulcer (p = 0.037), tumor size (p = 0.009), and prediction
of the presence of lymph node metastasis in CT scans
(p = 0.002) were independent predictive factors for
lymph node metastasis (Table 4).
Association between CT scans and EUS results and lymph
node metastasis
The correspondence between preoperative CT scan and
EUS results and pathological lymph node metastasis is
shown in Table 5. CT scan results were obtained from
all enrolled patients, whereas EUS results were available
from 491 patients (47.1 %). Prediction of the presence of
lymph node metastasis in CT scan was the only signifi-
cant predictor for lymph node metastasis (p = 0.002).
The sensitivity, specificity, positive predictive value, negative
predictive value, overstaging, and understaging of preopera-
tive prediction of the presence of lymph node metastasis by
CT scan were 12.2, 96.6, 21.4, 93.5, 3.2, and 6.2 %,
respectively (Additional file 2: Figure S2).
Receiver operating characteristics curves using
independent predictive factors
Receiver operating characteristics curves were constructed
by the probability of the finally selected logistic regression
models in each postoperative (the model including age,
tumor size, and T-stage, Table 3) and preoperative (the
model including age, ulcer, tumor size, and prediction of
the presence of lymph node metastasis in CT scan, Table 4)
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values and the event (lymph node metastasis). Figure 2
depicted the predictive performance of both multivariate
models in postoperative and preoperative values.
Receiver operating characteristics were analyzed for
area under the curve, sensitivity, specificity, positive pre-
dictive value, and negative predictive value using postop-
erative independent predictive factors, and were 0.824,
81.1 %, 71.4 %, 2.0 %, and 82.2 %, respectively. By con-
trast, area under the curve, sensitivity, specificity, posi-
tive predictive value, and negative predictive value of
receiver operating characteristics using preoperative in-
dependent predictive factors were 0.660, 68.9 %, 54.6 %,
4.3 %, and 89.6 %, respectively.
Discussion
We analyzed preoperative and postoperative predictive
factors for the presence of lymph node metastasis in
clinical stage early gastric cancer, and created predic-
tion models using both independent preoperative and
postoperative factors. The prediction model using
postoperative independent factors was quite reliable
(area under the curve = 0.812), whereas the one using
preoperative factors was less reliable (area under the
curve = 0.660). The prediction of the presence of
lymph node metastasis in preoperative CT scan had
the highest odds ratio among independent preopera-
tive predictive factors; however, 3.2 % of patients were
understaged and 6.2 % of patients were overstaged.
Thus, CT scan is not reliable enough for prediction
of the presence of lymph node metastasis, although it
appears to be the most reliable tool in current
practice.
One possible reason why preoperative values are
not reliable enough to accurately predict the presence
of lymph node metastasis is due to the discrepancy
between preoperative and postoperative values. Post-
operative tumor size is determined by measuring
Table 1 Baseline characteristics of all patients
Variable Preoperative
(number, %)
Postoperative
(number, %)
Age (mean ± SD, range) (years) 58.0 ± 11.7 (26–87)
BMI (mean ± SD, range) (kg/m2) 23.6 ± 3.0
(15.1 − 35.4)
Gender
Male 625 (60.0)
Female 417 (40.0)
Tumor size (mean ± SD, range) (mm)
Size using EGD (n = 631) 16.1 ± 8.0 (2–60) −
Size using EUS (n = 479) 16.4 ± 5.9 (3–40) −
Pathological size − 21.1 ± 14.8
(1–165)
Ulcer
Positive 66 (6.3) 245 (23.5)
Negative 976 (93.7) 797 (76.5)
Tumor location
Upper third 146 (14.0) 127 (12.2)
Middle or lower third 896 (86.0) 915 (87.8)
Gross type
0-Ia 29 (2.8) 18 (1.7)
0-IIa 278 (26.7) 34 (3.3)
0-IIb 224 (21.5) 184 (17.7)
0-IIc 428 (41.1) 667 (64.0)
0-III 83 (8.0) 62 (6.0)
AGC 0 77 (7.4)
Histology
Papillary 1 (0.1) 1 (0.1)
Well differentiated 165 (15.8) 125 (12.0)
Moderately differentiated 260 (25.0) 264 (25.3)
Poorly differentiated 252 (24.2) 273 (26.2)
Signet ring cell 364 (34.9) 364 (34.9)
Mucinous 0 2 (0.2)
Carcinoma with lymphoid stroma 0 13 (1.2)
Tumor detectability in CT scan
Detectable 210 (20.2) −
Undetectable 832 (79.8) −
Presence of LMN in CT scan
Suspected 42 (4.0) −
Unsuspected 1000 (96.0) −
NLR 2.00 ± 1.32 (0.09
− 29.56)
−
Tumor depth
Mucosa − 588 (56.4)
Submucosa − 373 (36.0)
Proper muscle − 56 (5.4)
Table 1 Baseline characteristics of all patients (Continued)
Subserosa − 10 (1.0)
Serosa invasion − 15 (1.4)
Lymph node classification
pN0 − 968 (92.9)
pN1 − 42 (4.0)
pN2 − 23 (2.2)
pN3a − 7 (0.7)
pN3b − 2 (0.2)
Count of retrieved lymph nodes
(mean ± SD, range)
− 32.6 ± 11.9
(5–74)
SD standard deviation, BMI body-mass index, EGD esophagogastroduodenoscopy,
EUS endoscopic ultrasonography, AGC advanced gastric cancer, LNM lymph node
metastasis, CT computed tomography, NLR neutrophil-lymphocyte ratio
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formalin-fixed specimens, whereas preoperative size is
estimated from EGD or EUS results. The lesion
border can be ambiguous, and it is challenging to ac-
curately identify the lesion extent preoperatively.
Tumor size measurement depends on the expertise of
endoscopists. Postoperative specimens are fixed with
formalin, which induces shrinkage of pathological
samples. These factors often lead to discrepancies be-
tween preoperative and postoperative tumor size mea-
surements [17, 18]. Histological heterogeneity is one
of the distinctive characteristics of gastric cancer.
There was usually a discrepancy between preoperative
and postoperative histology results, which we also
confirmed in the present study. The amount of tissue
obtained through biopsy is usually limited, and it is
taken primarily from mucosa, so the biopsy histology
does not always represent the most dominant histology
type of the lesion. According to the literature, the reported
percentage of histological discrepancy in early gastric can-
cer ranges from 16.3 to 53.7 % [21–25]. This can explain
why postoperative histology was significant for lymph
node metastasis in the present study, whereas preopera-
tive histology was not. Pathological T-stage is generally
related to lymph node metastasis, which is why it is in-
cluded in endoscopic submucosal dissection criteria [11].
If an accurate and precise preoperative assessment of
tumor depth can be achieved, it would be helpful for pre-
dicting the presence of lymph node metastasis. However,
this is still challenging, and preoperative diagnosis of
tumor depth inherently contains some degree of inaccur-
acy even using EUS [26, 27].
Lymph node size is a common measurement when
lymph nodes are assessed using CT scan. However, Monig
et al. reported that mean diameter of metastatic lymph
node was 6.0 mm, whereas that of tumor-free nodes was
4.1 mm. They also reported that the percentage of meta-
static lymph nodes larger than 6 and 10 mm were 45 and
9.7 %, respectively, with a 10 % shrinkage factor during
laboratory preparation [28]. A report by Park et al. on
preoperative CT scans of pathologically lymph node
metastatic-free patients concluded that lymph nodes
larger than 8 mm in the short-axis can be detected in
14.9 % of early gastric cancer patients and 44.2 % of ad-
vanced gastric cancer patients. Those reports suggest
that prediction of the presence of lymph node metasta-
sis using CT scans cannot be completely accurate as
long as criteria of the presence of lymph node metasta-
sis include the lymph node size.
Alternative methods for prediction of the presence of
lymph node metastasis include fluorodeoxyglucose positron
emission tomography (FDG-PET) and EUS. FDG-PET is a
preoperative diagnostic tool in various fields including
Table 2 Correspondence between preoperative and postoperative
results regarding existence of ulcer, gross type, and histology
Postoperative p-value*
Preoperative Ulcer Negative Positive
Negative 758 218 <0.001
Positive 39 27
Gross type I IIa IIb IIc III AGC
I 10 3 4 6 1 5 <0.001
IIa 4 16 47 175 15 21
IIb 1 5 79 121 4 14
IIc 2 9 46 324 21 26
III 1 2 8 41 21 11
AGC 0 0 0 0 0 0
Histology Pap WD MD PD Muc Sig CLS
Pap 0 0 0 0 0 1 0 <0.001
WD 0 92 62 8 0 3 0
MD 0 30 161 58 0 7 4
PD 0 3 34 141 1 65 8
Muc 0 0 0 0 0 0 0
Sig 1 0 7 66 1 288 1
CLS 0 0 0 0 0 0 0
*p-values were obtained using McNemar analysis
AGC advanced gastric cancer, Pap papillary adenocarcinoma,WD well differentiated
adenocarcinoma, MD moderately differentiated adenocarcinoma, PD poorly
differentiated adenocarcinoma, Muc mucinous adenocarcinoma, Sig signet ring cell
carcinoma, CLS carcinoma with lymphoid stroma
Fig. 1 Scatter plot using postoperative and preoperative combined
tumor sizes
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gastric cancer. However, FDG-PET has low sensitivity, and
is not currently a reliable tool for predicting the presence of
lymph node metastasis and identifying early gastric cancer
[29–31]. A meta-analysis by Cardoso et al. reported that
the pooled accuracy of N-stage prediction by EUS was 64 %
(95 % confidence interval = 43− 84 %) [27]. EUS also was
not a significantly reliable predictor in the current study.
Therefore, FDG-PETand EUS cannot completely overcome
the current lack of prediction accuracy.
Another method for prediction of the presence of lymph
node metastasis is required. Sentinel node navigation surgery
is a possible and promising solution. Application of sentinel
node navigation surgery using dye-based or radioisotope-
based techniques has been explored in the gastric cancer
field [32–34]. Sentinel node navigation surgery using near-
infrared imaging together with indocyanine green injection
has been introduced to several fields including gastric cancer
[35–39]. Optimized sentinel node navigation surgery should
allow accurate detection of sentinel lymph nodes and real-
time observation of lymphatic flow. However, a standard
method for sentinel node navigation surgery has not yet been
established, and the possibility of skip metastasis should al-
ways be considered. A multicenter randomized prospective
clinical trial of sentinel node navigation surgery is ongoing in
Korea to validate sentinel node navigation surgery for clinical
application (NCT number 01804998) (https://clinicaltrials.
gov/ct2/show/NCT018r04998?term=sentinel+and+gastric+
cancer&rank=3). Therefore, a surgical strategy should be
considered for each patient on a case-by-case basis according
to current guidelines until accurate preoperative diagnostic
methods for the presence of lymph node metastasis can be
established.
The present study has several limitations. First, it is a
retrospective study. Second, there was a selection bias be-
cause clinical stage early gastric cancer patients who
underwent endoscopic submucosal dissection were not in-
cluded unless their tumors met exclusion criteria for
endoscopic submucosal dissection and required subse-
quent surgery. Third, precise information regarding pre-
operative tumor depth was not fully available because
EUS was not performed for all patients in the cohort.
Fourth, the preoperative tumor sizes of some patients
Table 3 Univariate and multivariate analyses predicting LNM using postoperative values
Variable Univariate Multivariate
OR (95 % CI) p-value OR (95 % CI) p-value
Gender Male 1 0.118
Female 1.46 (0.91–2.34)
Agea 0.98 (0.96–0.99) 0.025 0.97 (0.94–0.99) 0.002
BMIa 1.00 (0.93–1.08) 0.977
Gross type 0-I, IIa 1 <0.001
IIb 0.51 (0.13–2.28)
IIc, III 0.92 (0.28–3.09)
AGC 8.33 (2.37–29.29)
Histology Pap, WD, MD 1 0.001
Muc, PD 2.65 (1.51–4.64) 0.001
Sig 0.86 (0.45–1.66) 0.654
CLS 0.0 (0.00–0.00) 0.999
Ulcer Negative 1 0.113
Positive 1.52 (0.91–2.54)
Location Upper third 1 0.145
Lower or middle third 0.63 (0.33–1.18)
Tumor sizea 1.03 (1.02–1.05) <0.001 1.02 (1.01–1.04) <0.001
T-stage Mucosa 1 <0.001 1 <0.001
Submucosa 5.13 (2.63–9.99) <0.001 5.44 (2.76–10.71) <0.001
Proper muscle 11.73 (4.90–28.08) <0.001 10.23 (4.21–24.84) <0.001
Subserosa 192.0 (36.82–1001.32) <0.001 149.40 (27.21–820.33) <0.001
Serosa invasion 42.0 (13.11–134.56) <0.001 28.62 (8.32–98.42) <0.001
aAnalyses were performed using continuous values
LNM lymph node metastasis, OR odds ratio, CI confidence interval, BMI body-mass index, Pap papillary adenocarcinoma, WD well differentiated adenocarcinoma,
MD moderately differentiated adenocarcinoma, Muc mucinous adenocarcinoma, PD poorly differentiated adenocarcinoma, Sig signet cell ring carcinoma,
CLS carcinoma with lymphoid stroma
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were missing, although they were compensated using lin-
ear regression analysis.
Conclusions
In conclusion, obvious discrepancies exist between pre-
operative and postoperative diagnostic values for the
presence of lymph node metastasis for early gastric can-
cer. The prediction sensitivity and positive predictive
value of the presence of lymph node metastasis using
CT scan is low, but it currently remains as the most
reliable tool. Predicting the presence of lymph node
metastasis of clinical stage early gastric cancer is still
Table 5 Correspondence between preoperative CT and EUS results and pathological LNM
LNM (−) LNM (+) p-value
CT Tumor detectability Undetectable 776 (80.2 %) 56 (75.7 %) 0.367
Detectable 192 (19.8 %) 18 (24.3 %)
Presence of LNM Unsuspected 935 (96.6 %) 65 (87.8 %) 0.002
Suspected 33 (3.4 %) 9 (12.2 %)
EUSa Tumor depth Mucosa 151 (33.0 %) 10 (30.3 %) 0.298
Submucosa 283 (61.8 %) 20 (60.6 %)
Proper muscle 22 (4.8 %) 2 (6.1 %)
Serosa exposure 2 (0.4 %) 1 (3.0 %)
Presence of LNM Unsuspected 442 (96.5 %) 30 (90.9 %) 0.128
Suspected 16 (3.5 %) 3 (9.1 %)
aData from 491 patients were available
LNM lymph node metastasis, CT computed tomography, EUS endoscopic ultrasonography
Table 4 Univariate and multivariate analyses predicting LNM using preoperative values
Variable Univariate Multivariate
OR (95 % CI) p-value OR (95 % CI) p-value
Gender Male 1 0.118
Female 1.46 (0.91–2.34)
Agea 0.98 (0.96–0.99) 0.025 0.98 (0.96–0.99) 0.017
BMIa 1.00 (0.93–1.08) 0.977
Gross type 0-I, IIa 1 0.585
IIb 0.70 (0.35–1.39) 0.304
IIc, III 0.86 (0.50–1.45) 0.563
Histology Pap, WD, MD 1 0.515
PD, Muc 1.36 (0.76–2.43) 0.300
Sig 1.00 (0.57–1.76) 0.991
Ulcer Negative 1 0.037 1 0.037
Positive 2.21 (1.05–4.67) 2.25 (1.05–4.81)
Location Upper third 1 0.893
Lower or middle third 1.05 (0.54–2.09)
Tumor sizea 1.04 (1.01–1.07) 0.010 1.04 (1.01–1.07) 0.009
NLRa 1.08 (0.95–1.22) 0.228
Tumor detectability in CT scan Undetectable 1 0.355
Detectable 1.30 (0.75–2.26)
Presence of LMN in CT scan Unsuspected 1 0.001 1 0.002
Suspected 3.92 (1.80–8.55) 3.57 (1.62–7.88)
aAnalyses were performed using continuous values
LNM lymph node metastasis, OR odds ratio, CI confidence interval, BMI body-mass index, Pap papillary adenocarcinoma, WD well differentiated adenocarcinoma,
MD moderately differentiated adenocarcinoma, Muc mucinous adenocarcinoma, PD poorly differentiated adenocarcinoma, Sig signet cell ring carcinoma,
CLS carcinoma with lymphoid stroma, NLR neutrophil-lymphocyte ratio, CT computed tomography
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challenging, and surgeons need to be aware of limitations
in preoperative prediction accuracy of the presence of
lymph node metastasis for early gastric cancer.
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Additional file 1: Figure S1. Scheme showing how tumor sizes were
obtained in the present study. EGC, early gastric cancer; EGD,
esophagogastroduodenoscopy; CT, computed tomography; EUS,
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Additional file 2: Figure S2. Scheme showing the relationship
between clinical and pathological lymph node assessments. cEGC: clinical
stage early gastric cancer; cLN, clinical stage lymph node; pLN: pathological
stage lymph node. (TIF 88 kb)
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